{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:16:49Z","timestamp":1781662609971,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T00:00:00Z","timestamp":1464307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U54 HD071600-01 09\/26\/2011-06\/30\/2016"],"award-info":[{"award-number":["U54 HD071600-01 09\/26\/2011-06\/30\/2016"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K23AI089978"],"award-info":[{"award-number":["K23AI089978"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005850","name":"Great Lakes Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research","doi-asserted-by":"publisher","award":["AI057153"],"award-info":[{"award-number":["AI057153"]}],"id":[{"id":"10.13039\/100005850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s10096-016-2682-0","type":"journal-article","created":{"date-parts":[[2016,5,27]],"date-time":"2016-05-27T02:11:36Z","timestamp":1464315096000},"page":"1441-1447","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effects of vancomycin versus nafcillin in enhancing killing of methicillin-susceptible Staphylococcus aureus causing bacteremia by human cathelicidin LL-37"],"prefix":"10.1007","volume":"35","author":[{"given":"J.","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schweizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Thienphrapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Nizet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sakoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,27]]},"reference":[{"issue":"7","key":"2682_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011432","volume":"5","author":"ML Schweizer","year":"2010","unstructured":"Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, Thom KA, Sakoulas G, Perencevich EN (2010) Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study. PLoS One 5(7), e11432. doi: 10.1371\/journal.pone.0011432","journal-title":"PLoS One"},{"issue":"3","key":"2682_CR2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/infdis\/jir270","volume":"204","author":"NE Holmes","year":"2011","unstructured":"Holmes NE, Turnidge JD, Munckhof WJ, Robinson JO, Korman TM, O\u2019Sullivan MV, Anderson TL, Roberts SA, Gao W, Christiansen KJ, Coombs GW, Johnson PD, Howden BP (2011) Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. J Infect Dis 204(3):340\u2013347. doi: 10.1093\/infdis\/jir270","journal-title":"J Infect Dis"},{"issue":"1","key":"2682_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1128\/AAC.00700-07","volume":"52","author":"SH Kim","year":"2008","unstructured":"Kim SH, Kim KH, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW (2008) Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 52(1):192\u2013197. doi: 10.1128\/AAC.00700-07","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"2682_CR4","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/cid\/cit560","volume":"57","author":"KW McConeghy","year":"2013","unstructured":"McConeghy KW, Bleasdale SC, Rodvold KA (2013) The empirical combination of vancomycin and a beta-lactam for Staphylococcal bacteremia. Clin Infect Dis 57(12):1760\u20131765. doi: 10.1093\/cid\/cit560","journal-title":"Clin Infect Dis"},{"key":"2682_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/1471-2334-11-279","volume":"11","author":"ML Schweizer","year":"2011","unstructured":"Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, Thom KA, Cosgrove SE, Sakoulas G, Perencevich EN (2011) Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis 11:279. doi: 10.1186\/1471-2334-11-279","journal-title":"BMC Infect Dis"},{"issue":"2","key":"2682_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1086\/510386","volume":"44","author":"ME Stryjewski","year":"2007","unstructured":"Stryjewski ME, Szczech LA, Benjamin DK Jr, Inrig JK, Kanafani ZA, Engemann JJ, Chu VH, Joyce MJ, Reller LB, Corey GR, Fowler VG Jr (2007) Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 44(2):190\u2013196. doi: 10.1086\/510386","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2682_CR7","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1128\/AAC.00485-11","volume":"55","author":"S Lee","year":"2011","unstructured":"Lee S, Choe PG, Song KH, Park SW, Kim HB, Kim NJ, Kim EC, Park WB, Oh MD (2011) Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia? Antimicrob Agents Chemother 55(11):5122\u20135126. doi: 10.1128\/AAC.00485-11","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2682_CR8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MOH.0b013e32831ac517","volume":"16","author":"A Nijnik","year":"2009","unstructured":"Nijnik A, Hancock RE (2009) The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol 16(1):41\u201347","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"2682_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cellimm.2012.11.009","volume":"280","author":"D Vandamme","year":"2012","unstructured":"Vandamme D, Landuyt B, Luyten W, Schoofs L (2012) A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol 280(1):22\u201335. doi: 10.1016\/j.cellimm.2012.11.009","journal-title":"Cell Immunol"},{"issue":"6","key":"2682_CR10","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2174\/13892037113149990067","volume":"14","author":"JH Wong","year":"2013","unstructured":"Wong JH, Ye XJ, Ng TB (2013) Cathelicidins: peptides with antimicrobial, immunomodulatory, anti-inflammatory, angiogenic, anticancer and procancer activities. Curr Protein Pept Sci 14(6):504\u2013514","journal-title":"Curr Protein Pept Sci"},{"issue":"4","key":"2682_CR11","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1128\/AAC.05131-11","volume":"56","author":"SM McGillivray","year":"2012","unstructured":"McGillivray SM, Tran DN, Ramadoss NS, Alumasa JN, Okumura CY, Sakoulas G, Vaughn MM, Zhang DX, Keiler KC, Nizet V (2012) Pharmacological inhibition of the ClpXP protease increases bacterial susceptibility to host cathelicidin antimicrobial peptides and cell envelope-active antibiotics. Antimicrob Agents Chemother 56(4):1854\u20131861. doi: 10.1128\/AAC.05131-11","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"2682_CR12","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1128\/IAI.71.7.3730-3739.2003","volume":"71","author":"K Midorikawa","year":"2003","unstructured":"Midorikawa K, Ouhara K, Komatsuzawa H, Kawai T, Yamada S, Fujiwara T, Yamazaki K, Sayama K, Taubman MA, Kurihara H, Hashimoto K, Sugai M (2003) Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect Immun 71(7):3730\u20133739","journal-title":"Infect Immun"},{"issue":"2","key":"2682_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00109-013-1100-7","volume":"92","author":"G Sakoulas","year":"2014","unstructured":"Sakoulas G, Okumura CY, Thienphrapa W, Olson J, Nonejuie P, Dam Q, Dhand A, Pogliano J, Yeaman MR, Hensler ME, Bayer AS, Nizet V (2014) Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus. J Mol Med (Berl) 92(2):139\u2013149. doi: 10.1007\/s00109-013-1100-7","journal-title":"J Mol Med (Berl)"},{"issue":"4","key":"2682_CR14","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1096\/fj.06-6802com","volume":"21","author":"SA Kristian","year":"2007","unstructured":"Kristian SA, Timmer AM, Liu GY, Lauth X, Sal-Man N, Rosenfeld Y, Shai Y, Gallo RL, Nizet V (2007) Impairment of innate immune killing mechanisms by bacteriostatic antibiotics. FASEB J 21(4):1107\u20131116. doi: 10.1096\/fj.06-6802com","journal-title":"FASEB J"},{"issue":"2","key":"2682_CR15","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1128\/AAC.05551-11","volume":"56","author":"G Sakoulas","year":"2012","unstructured":"Sakoulas G, Bayer AS, Pogliano J, Tsuji BT, Yang SJ, Mishra NN, Nizet V, Yeaman MR, Moise PA (2012) Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 56(2):838\u2013844. doi: 10.1128\/AAC.05551-11","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2682_CR16","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1128\/AAC.02274-13","volume":"58","author":"G Sakoulas","year":"2014","unstructured":"Sakoulas G, Rose W, Nonejuie P, Olson J, Pogliano J, Humphries R, Nizet V (2014) Ceftaroline restores daptomycin activity against daptomycin-nonsusceptible vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 58(3):1494\u20131500. doi: 10.1128\/AAC.02274-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"2682_CR17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1086\/596314","volume":"48","author":"AF Gombart","year":"2009","unstructured":"Gombart AF, Bhan I, Borregaard N, Tamez H, Camargo CA Jr, Koeffler HP, Thadhani R (2009) Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Clin Infect Dis 48(4):418\u2013424. doi: 10.1086\/596314","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2682_CR18","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1093\/jac\/dkn106","volume":"61","author":"K Ouhara","year":"2008","unstructured":"Ouhara K, Komatsuzawa H, Kawai T, Nishi H, Fujiwara T, Fujiue Y, Kuwabara M, Sayama K, Hashimoto K, Sugai M (2008) Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus. J Antimicrob Chemother 61(6):1266\u20131269. doi: 10.1093\/jac\/dkn106","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"2682_CR19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/cid\/cir340","volume":"53","author":"A Dhand","year":"2011","unstructured":"Dhand A, Bayer AS, Pogliano J, Yang SJ, Bolaris M, Nizet V, Wang G, Sakoulas G (2011) Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding. Clin Infect Dis 53(2):158\u2013163. doi: 10.1093\/cid\/cir340","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2682_CR20","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJMoa053783","volume":"355","author":"VG Fowler Jr","year":"2006","unstructured":"Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, F\u00e4tkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE; S. aureus Endocarditis and Bacteremia Study Group (2006) Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 355(7):653\u2013665. doi: 10.1056\/NEJMoa053783","journal-title":"N Engl J Med"},{"issue":"3","key":"2682_CR21","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1128\/AAC.00869-07","volume":"52","author":"WE Rose","year":"2008","unstructured":"Rose WE, Leonard SN, Sakoulas G, Kaatz GW, Zervos MJ, Sheth A, Carpenter CF, Rybak MJ (2008) Daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother 52(3):831\u2013836. doi: 10.1128\/AAC.00869-07","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"2682_CR22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.tim.2009.06.006","volume":"17","author":"GY Liu","year":"2009","unstructured":"Liu GY, Nizet V (2009) Color me bad: microbial pigments as virulence factors. Trends Microbiol 17(9):406\u2013413. doi: 10.1016\/j.tim.2009.06.006","journal-title":"Trends Microbiol"},{"issue":"7","key":"2682_CR23","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1128\/AAC.49.7.2687-2692.2005","volume":"49","author":"G Sakoulas","year":"2005","unstructured":"Sakoulas G, Eliopoulos GM, Fowler VG Jr, Moellering RC Jr, Novick RP, Lucindo N, Yeaman MR, Bayer AS (2005) Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function. Antimicrob Agents Chemother 49(7):2687\u20132692. doi: 10.1128\/AAC.49.7.2687-2692.2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2682_CR24","doi-asserted-by":"publisher","first-page":"C105","DOI":"10.1152\/ajpcell.00158.2010","volume":"300","author":"FJ Byfield","year":"2011","unstructured":"Byfield FJ, Wen Q, Leszczynska K, Kulakowska A, Namiot Z, Janmey PA, Bucki R (2011) Cathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial barrier permeability. Am J Physiol Cell Physiol 300(1):C105\u2013C112. doi: 10.1152\/ajpcell.00158.2010","journal-title":"Am J Physiol Cell Physiol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2682-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-016-2682-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2682-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:35:21Z","timestamp":1559108121000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-016-2682-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,27]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["2682"],"URL":"https:\/\/doi.org\/10.1007\/s10096-016-2682-0","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,27]]}}}